TScan Therapeutics (NASDAQ:TCRX – Get Rating) is one of 283 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare TScan Therapeutics to related companies based on the strength of its risk, earnings, profitability, analyst recommendations, dividends, institutional ownership and valuation. Risk & Volatility TScan […]